Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Asterias Biotherapeutics Inc.
DescriptionHuman embryonic stem cell (hESC)-derived oligodendrocyte progenitor cells
Molecular Target
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy: Stem cell
Latest Stage of DevelopmentPhase I/II
Standard IndicationSpinal cord injury (SCI)
Indication DetailsTreat cervical spinal cord injury (SCI)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today